n | 144 | |||
Gender (M:F) | 62:82 | |||
Age (years) | 58.52 | ± | 12.65 | |
Duration of diabetes (years) | 11.74 | ± | 6.07 | |
Hight (cm) | 162.30 | ± | 9.11 | |
Weight (kg) | 68.89 | ± | 12.92 | |
BMI (kg/m2) | 26.11 | ± | 4.11 | |
HbA1c (NGSP) (%) | 8.20 | ± | 0.68 | |
SBP (mmHg) | 126.46 | ± | 12.27 | |
DBP (mmHg) | 74.94 | ± | 11.62 | |
Concomitant drugs used before the metformin dose increase. (n) | SU | 31 | ||
SU + DPP-4 inhibitor | 16 | |||
SU + insulin | 11 | |||
SU + α-GI | 8 | |||
SU + GLP-1 receptor agonist | 1 | |||
SU + TZ | 1 | |||
SU + insulin + α-GI | 1 | |||
Insulin | 28 | |||
Insulin +DPP-4 inhibitor | 1 | |||
Insulin + α-GI | 1 | |||
Insulin + TZ | 1 | |||
DPP-4 inhibitor | 10 | |||
DPP-4 inhibitor + α-GI | 1 | |||
Glinide | 2 | |||
Glinide + α-GI | 1 | |||
α-GI | 2 | |||
TZ | 2 | |||
None | 26 | |||
Complications | Hypertension | 30 | ||
Hypertension + dyslipidemia | 37 | |||
Hypertension + angine pectosis | 1 | |||
Hypertension + dyslipidemia + ASO | 1 | |||
Hypertension + dyslipidemia + Af | 1 | |||
dyslipidemia | 21 | |||
OMI | 3 | |||
Angine pectosis | 2 | |||
Af | 1 | |||
ASO | 1 | |||
Bronchial asthma | 1 | |||
Hyperuricemia | 1 | |||
None | 44 | |||